**Boston, November 25, 2025 — Leads & Copy —** Verastem Oncology (Nasdaq: VSTM) will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on Tuesday, December 2, 2025, at 10:25 a.m. ET in Miami, Florida.
The management team of Verastem Oncology, a biopharmaceutical company focused on developing new medicines for RAS/MAPK pathway-driven cancers, will be participating in the discussion.
The live webcast can be accessed under “Events & Presentations” on the company’s website.
A replay of the webcast will be archived on the website for about 90 days after the presentation.
Verastem Oncology markets AVMAPKI™ FAKZYNJA™ CO-PACK in the U.S. The company’s pipeline is focused on small molecule drugs that inhibit critical signaling pathways in cancer promoting cancer cell survival and tumor growth, including RAF/MEK inhibition, FAK inhibition, and KRAS G12D inhibition.
For more information, visit Verastem Oncology’s website and follow them on LinkedIn.
Source: Verastem Oncology
